Comparative biochemical kinase activity analysis identifies rivoceranib as a highly selective VEGFR2 inhibitor
CANCER CHEMOTHERAPY AND PHARMACOLOGY（2023）
关键词
VEGFR2,Angiogenesis,Oral kinase inhibitor,Rivoceranib,Comparative kinase activity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要